Similar effects of diets high in oleic or linoleic acids on coagulation and fibrinolytic factors in healthy humans

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 9, Issue 2, 1999, Pages 65-72

  Turpeinen, A M ^a   Mutanen, M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Coagulation; Fibrinolysis; Linoleic acid; Oleic acid

Indexed keywords

FATTY ACID; HEMOSTATIC AGENT; LINOLEIC ACID; OLEIC ACID;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FAT INTAKE; FEMALE; HUMAN; MALE; METABOLISM; PHYSIOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADULT; BLOOD COAGULATION; DIETARY FATS; FATTY ACIDS; FEMALE; HEMOSTATICS; HUMANS; LINEAR MODELS; LINOLEIC ACIDS; MALE; OLEIC ACIDS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0033107589     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Genest J Jr, Cohn JS (1995) Clustering of cardiovascular risk factors: targeting high-risk individuals. Am J Cardiol 76: 8-20A
2. Ernst E (1993) The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 100: 1-12
3. Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WRS, Stirling Y, Thompson SG (1986) Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 6: 533-537
4. Hamsten A, Wirman B, de Faire U, Blombäck M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313: 1557-1563
5. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ (1994) Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 90: 2236-2240
6. Marckmann P (1995) Diet, blood coagulation and fibrinolysis. Danish Med Bull 42: 410425
7. Lopez-Segura F, Velasco F, Lopez-Miranda J, Castro P, Lopez-Pedrera R, Blanco A, Jimenez-Pereperez J, Torres A, Trujillo J, Ordovas JM, Perez-Jimenez F (1996) Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type I. Arterioscler Thromb Vasc Biol 16: 82-88
8. Rasmussen O, Thomsen C, Ingerslev J, Hermansen K (1994) Decrease in von Willebrand Factor levels after a high-monounsaturated fat diet in non-insulin dependent diabetic subjects. Metabolism 43: 1406-1409
9. Heinrich J, Wahrburg U, Marting H, Assmann G (1990) The effects of diets, rich in mono-or polyunsaturated fatty acids, on lipid metabolism and haemostasis. Fibrinolysis 4: 76-78
10. Pike RL, Brown ML (1984) Nutrition-an integrated approach. New York: Macmillan Publishing Company, 736-794
11. Folch J, Lees M, Sloane-Stanley GHS (1957) A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509
12. Stoffel W, Chu F, Ahrens EH Jr (1959) Analysis of long-chain fatty acids by gas-liquid chromatography. Anal Chem 31: 307-308
13. Wilkinson L (1989) SYSTAT: The system for statistics. Evanston: SYSTAT, Inc, p 724
14. Cohen J, Cohen B (1975) Applied multiple regression/correlation analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale, New Jersey
15. Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE, Wilkinson WH, Meade TW (1986) Association between dietary fat intake and plasma factor VII coagulant activity - A predictor of cardiovascular mortality. Atherosclerosis 60: 269-277
16. Marckmann P, Sandström B, Jespersen J (1994) Low-fat, high-fiber diet favourably affects several independent risk markers of ischaemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 59: 935-939
17. Marckmann P, Sandström B, Jespersen J (1993) Favourable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 13:505-511
18. Marckmann P, Sandström B, Jespersen J (1990) Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 80: 227-233
19. Foley M, Ball M, Chisholm A, Duncan A, Spears G, Mann J (1992) Should mono-or polyunsaturated fats replace saturated fat in the diet? Eur J Clin Nutr 46: 429436
20. Østerud B, Elvevoll E, Barstad H, Brox J, Halvorsen H, Lia K, Olsen JO, Olsen RL, Sissener C, Rekdal Ø, Vognild E (1995) Effect of marine oils supplementation on coagulation and cellular activation in whole blood. Lipids 30: 1111-1115
21. Bladbjerg EM, Tholstrup T, Marckmann P, Sandström B, Jespersen J (1995) Dietary changes in fasting levels of factor VII coagulant activity (VII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteins. Thromb Haemost 73: 239-242
22. Tholstrup T, Marckmann P, Jespersen J, Sandström B (1994) Fat high in stearic acid favourably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic or high in myristic and lauric acids. Am J Clin Nutr 59: 371-377
23. Tholstrup T, Marckmann P, Jespersen J, Vessby B, Jart A, Sandström B (1994) Effect on blood lipids, coagulation, and fibrinolysis of a fat high in myristic acid and a fat high in palmitic acid. Am J Clin Nutr 60: 919-925
24. Rogers S, Yarnell JWG, Fehily AM (1988) Nutritional determinant of haemostatic factors in the Caerphilly study. Eur J Clin Nutr 42: 197-205
25. Mortensen JZ, Schmidt EB, Nielsen AH, Dyerberg J (1983) The effect of N-6 and N-3 polyunsaturated fatty adds on haemostasis, blood lipids and blood pressure. Thromb Haemost 50: 543-546
26. Sanders TAB, Vickers M, Haines AP (1981) Effect on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic acid and docosahexaenoic acids, in healthy young men. Clin Sci 61: 317-324
27. Freese R, Mutanen M, Valsta LM, Salminen I (1994) Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/α-linolenic acid ratio on platelet aggregation. Thromb Haemost 71: 73-77
28. Freese R, Mutanen M (1997) Alpha-linolenic acid and marine long-chain n-3 fatty acids only slightly differ in their effects on hemostatic factors in healthy subjects. Am J Clin Nutr 66: 591-595
29. Bick RL (1982) Clinical relevance of antithrombin III. Semin Thromb Haemost 8: 276-287
30. Meade TW, Dyer S, Howarth DJ, Imeson JD, Stirling Y (1990) Antithrombin III and procoagulant activity: sex differences and effects of the menopause. Br J Haematol 74: 77-81
31. Meade TW, Cooper J, Miller GJ, Howard DJ, Stirling Y (1991) Antithrombin III and arterial disease. Lancet 338: 850-851
32. Conlan MG, Folsom AR, Finch A, Davis CE, Marcucci G, Sorlie P, Wu KK (1994) Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. Thromb Haemost 72: 551-556
33. Marckmann P, Jespersen J, Leth T, Sandström B (1991) Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. J Int Med 229: 317-323
34. Slabber M, Barnard HC, Kuyl JM, Badenhorst CJ (1992) Effect of a short-term very low caloric diet on plasma lipids, fibrinogen, and factor VII in obese subjects. Clin Biochem 25: 334-335
35. Wiman B (1996) Plasminogen activator inhibitor I in thrombotic disease. Curr Opinion Haematol 3: 372-378
36. Hamsten A, DeFaire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; ii: 3-9
37. Mutanen M, Aro A (1997) Coagulation and fibrinolysis factors in healthy subjects consuming high stearic or trans fatty acid diets. Thromb Haemost 77: 99-104
38. Cigolini M, Targher G, Seidell JC, Schiavon R, Manara F, Zenti MG, Mattioli C, De Sandre G (1994) Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men. Atherosclerosis 106: 139-147
39. Jensen T (1989) Increased level of von Willebrand factor in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Br Med J 298: 27-28
40. Solerte SB, Piovella F, Viola C, Schianca GC, Gamba G, Fioravanti M, Ferrari E (1985) Plasma fibronectin, von Willebrand factor antigen, and blood rheology: Associations with diabetic microvascular disease. Acta Diabetol Lat 22: 239-245
41. Porta M, La Selva M, Molinatti P, Molinatti GM (1987) Endothelial cell function in diabetic microangiopathy. Diabetologia 30: 601-609
42. Elms MJ, Bunce H, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN (1983) Measurement of crosslinked fibrin degradation products: an immunoassay using monoclonal antibodies. Thromb Haemost 50: 591-594
43. Fowkes FGR, Lowe GDO, Housley E, Rattray A, Rumley A, Elton RA, MacGregor IR, Dawes J (1993) Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 342: 84-86
44. Lassila R, Peltonen S, Lepäntalo M, Saarinen O, Kauhanen P, Manninen V (1993) Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb 13: 1738-1742
45. Herren T, Stricker H, Haeberli A, Do D-D, Straub PW (1994) Fibrin formation and degradation in patients with arteriosclerotic disease. Circulation 90: 2679-2686